Printer Friendly
The Free Library
19,573,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

AcryMed Inc. Receives FDA Market Approval for New Wound Care Dressing.


PORTLAND, Ore.--(BUSINESS WIRE)--Oct. 15, 1996--AcryMed Inc., a medical device company specializing in advanced technology products for wound care management, has received clearance from the U.S. Food and Drug administration (FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
) to market and distribute AcryNoodles Absorbent Wound Dressing.

The company intends to release the product under the brand name AcryDerm Strands Absorbent Wound Dressing into the $335 million moist wound dressing market within three months. AcryDerm Strands Absorbent Wound Dressing, covered by United States, New Zealand New Zealand (zē`lənd), island country (2005 est. pop. 4,035,000), 104,454 sq mi (270,534 sq km), in the S Pacific Ocean, over 1,000 mi (1,600 km) SE of Australia. The capital is Wellington; the largest city and leading port is Auckland. , and European (pending) patents, is a high exudate exudate /ex·u·date/ (eks´u-dat) a fluid with a high content of protein and cellular debris which has escaped from blood vessels and has been deposited in tissues or on tissue surfaces, usually as a result of inflammation.  absorbent moist wound dressing that is intended for use in heavily exudating cavitated acute and chronic wounds.

The engineering of the product has incorporated the company's core technology which is also used in AcryDerm Sheet Advanced Wound Dressing, currently marketed in several geographic regions of the United States.

"Wounds encountered in the clinical environment have increasingly challenged healthcare professionals and manufacturers to develop innovative protocols and devices to return patients to health rapidly and in a cost effective manner," said AcryMed President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  Bruce Gibbins. "AcryDerm Strands Absorbent Wound Dressing, the company's second product to incorporate our core technology, has been developed and cleared for market in response to that challenge."

AcryDerm Strands Absorbent Wound Dressing was designed specifically to aid in the treatment of cavitated wounds which have moderate to heavy exudate. Presented in a bound strand-like format, the dressing has the flexibility to be easily placed into a deep wound. Clinical studies have shown the dressing to effectively manage moderate to heavy exudate and to significantly enhance autolytic au·tol·y·sis  
n.
The destruction of tissues or cells of an organism by the action of substances, such as enzymes, that are produced within the organism. Also called self-digestion.
 debridement Debridement Definition

Debridement is the process of removing nonliving tissue from pressure ulcers, burns, and other wounds.
Purpose

Debridement speeds the healing of pressure ulcers, burns, and other wounds.
 while providing patient comfort.

The dressing can be used effectively with a wide variety of wounds, including burns, abrasions, pressure ulcers, diabetic ulcers, arterial insufficiency ulcers and venous stasis venous stasis Medtalk The pooling of venous blood in a particular region which, in the legs results in edema, hyperpigmentation and possibly ulceration  ulcers.

AcryMed Inc. is a closely held A phrase used to describe the ownership, management, and operation of a corporation by a small group of people.

In a closely held corporation, the same people often act as shareholders, directors, and officers, and no outside investors exist.
 medical device company that specializes in the development and distribution of sophisticated wound care products that can be used in all stages of wound care protocols in the professional hospital and alternate site healthcare markets.

The company's products exploit a patented core technology which is based on innovative uses of synthetic polymer technology. AcryMed's executive offices, R&D laboratory, and U.S. distribution center are located in Portland.

CONTACT: AcryMed Inc.

Bruce Gibbins or Annette Nemetz, 503/624-9830
COPYRIGHT 1996 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1996, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Oct 15, 1996
Words:373
Previous Article:Mississippi Chemical Corporation declares quarterly dividend.
Next Article:Computron Software, Inc., signs agreement with Ricoh Corp. for client/server solution.
Topics:



Related Articles
Don't let HCFA deny progress.
Solving the mysteries of wound care reimbursement.
Recent Developments in Wound Care Products.
Wound Care: What's Really Cost-Effective?
Teamwork: a winning approach to wound care. (Feature Article).
Antimicrobial wound Dressings. (Product Spotlight).

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles